Skip to main content
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1989 Jun;33(6):989. doi: 10.1128/aac.33.6.989

Antibiotic treatment of enterococcal infection.

J M Hamilton-Miller
PMCID: PMC284273  PMID: 2764551

Full text

PDF

Page 989

989

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Crider S. R., Colby S. D. Susceptibility of enterococci to trimethoprim and trimethoprim-sulfamethoxazole. Antimicrob Agents Chemother. 1985 Jan;27(1):71–75. doi: 10.1128/aac.27.1.71. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Goodhart G. L. In vivo v in vitro susceptibility of enterococcus to trimethoprim-sulfamethoxazole. A pitfall. JAMA. 1984 Nov 16;252(19):2748–2749. [PubMed] [Google Scholar]
  3. Hamilton-Miller J. M., Purves D. Enterococci and antifolate antibiotics. Eur J Clin Microbiol. 1986 Aug;5(4):391–394. [PubMed] [Google Scholar]
  4. Hamilton-Miller J. M., Purves D. Trimethoprim resistance and trimethoprim usage in and around The Royal Free Hospital in 1985. J Antimicrob Chemother. 1986 Nov;18(5):643–644. doi: 10.1093/jac/18.5.643. [DOI] [PubMed] [Google Scholar]
  5. Hamilton-Miller J. M. Reversal of activity of trimethoprim against gram-positive cocci by thymidine, thymine and 'folates'. J Antimicrob Chemother. 1988 Jul;22(1):35–39. doi: 10.1093/jac/22.1.35. [DOI] [PubMed] [Google Scholar]
  6. Hamilton-Miller J. M., Stewart S. Trimethoprim resistance in enterococci: microbiological and biochemical aspects. Microbios. 1988;56(226):45–55. [PubMed] [Google Scholar]
  7. Hoffmann S. A., Moellering R. C., Jr The enterococcus: "putting the bug in our ears". Ann Intern Med. 1987 May;106(5):757–761. doi: 10.7326/0003-4819-106-5-757. [DOI] [PubMed] [Google Scholar]
  8. Leclercq R., Derlot E., Duval J., Courvalin P. Plasmid-mediated resistance to vancomycin and teicoplanin in Enterococcus faecium. N Engl J Med. 1988 Jul 21;319(3):157–161. doi: 10.1056/NEJM198807213190307. [DOI] [PubMed] [Google Scholar]
  9. Maki D. G., Agger W. A. Enterococcal bacteremia: clinical features, the risk of endocarditis, and management. Medicine (Baltimore) 1988 Jul;67(4):248–269. [PubMed] [Google Scholar]
  10. Patterson J. E., Colodny S. M., Zervos M. J. Serious infection due to beta-lactamase-producing Streptococcus faecalis with high-level resistance to gentamicin. J Infect Dis. 1988 Nov;158(5):1144–1145. doi: 10.1093/infdis/158.5.1144. [DOI] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES